Event Title

Glucose Transporter Inhibitor DRB18 in the Treatment of Lung Cancer

Abstract

DRB18 is a new anticancer compound that blocks glucose uptake in cancer cells and works with other drugs to improve outcomes.

Keywords:

Biological Sciences, Cancer, Biomedical Sciences, Anticancer drugs, Cancer metabolism, video

Comments

.

Status

Undergraduate

Department

Biological Sciences

College

Honors Tutorial College

Campus

Athens

Faculty Mentor

Chen, Xiaozhuo

Streaming Media

Share

COinS
 

Glucose Transporter Inhibitor DRB18 in the Treatment of Lung Cancer

DRB18 is a new anticancer compound that blocks glucose uptake in cancer cells and works with other drugs to improve outcomes.